<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="review-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">pirogovestnik</journal-id><journal-title-group><journal-title xml:lang="ru">Вестник Национального медико-хирургического центра им. Н.И. Пирогова</journal-title><trans-title-group xml:lang="en"><trans-title>Bulletin of Pirogov National Medical &amp; Surgical Center</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2072-8255</issn><issn pub-type="epub">2782-3628</issn><publisher><publisher-name>Национальный медико-хирургический Центр им. Н.И. Пирогова</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.25881/20728255_2025_20_3_120</article-id><article-id custom-type="elpub" pub-id-type="custom">pirogovestnik-371</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ ЛИТЕРАТУРЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEWS</subject></subj-group></article-categories><title-group><article-title>КОМБИНИРОВАННОЕ ЛЕЧЕНИЕ БОЛЬНЫХ РАКОМ ЖЕЛУДКА С ПРИМЕНЕНИЕМ МИНИ-ИНВАЗИВНЫХ ТЕХНОЛОГИЙ</article-title><trans-title-group xml:lang="en"><trans-title>COMBINED TREATMENT OF GASTRIC CANCER USING MINIMALLY INVASIVE TECHNOLOGIES</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Греков</surname><given-names>Д. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Grekov</surname><given-names>D. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва</p></bio><bio xml:lang="en"><p>Moscow </p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кузьменко</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kuzmenko</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва </p></bio><bio xml:lang="en"><p>Moscow </p></bio><email xlink:type="simple">dr.kuzmenko@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Петросян</surname><given-names>Т. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Petrosyan</surname><given-names>T. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p> Москва </p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Андрейцев</surname><given-names>И. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Andreicev</surname><given-names>I. L.</given-names></name></name-alternatives><bio xml:lang="ru"><p> Москва </p></bio><bio xml:lang="en"><p>Moscow</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Титов</surname><given-names>К. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Titov</surname><given-names>K. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p> Москва </p></bio><bio xml:lang="en"><p> Moscow </p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Якомаскин</surname><given-names>В. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Yakomaskin</surname><given-names>V. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p> Москва </p></bio><bio xml:lang="en"><p> Moscow </p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ГБУЗ «Московский многопрофильный научно-клинический центр им. С.П. Боткина ДЗМ»;&#13;
ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Botkin Hospital;&#13;
Russian Medical Academy of Continuous Professional Education</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ГБУЗ «Московский многопрофильный научно-клинический центр им. С.П. Боткина ДЗМ»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Botkin Hospital</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ГБУЗ «Московский многопрофильный научно-клинический центр им. С.П. Боткина ДЗМ»;&#13;
ФГАОУ ВО «Российский университет дружбы народов»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Botkin Hospital;&#13;
RUDN University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>29</day><month>08</month><year>2025</year></pub-date><volume>20</volume><issue>3</issue><fpage>120</fpage><lpage>125</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Греков Д.Н., Кузьменко А.А., Петросян Т.В., Андрейцев И.Л., Титов К.С., Якомаскин В.Н., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Греков Д.Н., Кузьменко А.А., Петросян Т.В., Андрейцев И.Л., Титов К.С., Якомаскин В.Н.</copyright-holder><copyright-holder xml:lang="en">Grekov D.N., Kuzmenko A.A., Petrosyan T.V., Andreicev I.L., Titov K.S., Yakomaskin V.N.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://submit.pirogov-vestnik.ru/jour/article/view/371">https://submit.pirogov-vestnik.ru/jour/article/view/371</self-uri><abstract><p>Лечение больных раком желудка является одним из сложнейших разделов в онкологии и хирургии. В то время, как операция, по-прежнему является основным методом лечения больных раком желудка, анализ мировой литературы доказывает, что комбинированный подход с применением периоперационной химиотерапии улучшает отдаленный онкологический прогноз у пациентов с местнораспространенными формами рака желудка. Дискутабельным остается выбор хирургического доступа. В настоящее время мировой тенденцией в хирургии рака желудка является применение мини-инвазивных технологий. По данным литературы их применение в хирургии рака желудка позволяет снизить уровень операционной травмы, что в свою очередь приводит к меньшей кровопотере, снижению количества раневых осложнений и ранней активизации пациента и, соответственно, более раннего начала послеоперационного химиотерапевтического лечения. На сегодняшний день лапароскопический доступ в лечении ранних форм рака желудка является уже стандартом, при этом роль робот-ассистированных методик до конца не определена.Целью настоящей работы является выявить преимущества и недостатки робот – ассистированной хирургии рака желудка, как части комбинированного лечения пациентов с раком желудка, основываясь на обзоре мировой научной литературы.</p></abstract><trans-abstract xml:lang="en"><p>Gastric cancer treatment is one of the most complex and evolving fields in oncology and surgery. Although surgery remains the primary treatment option, global research indicates that a multimodal approach, including perioperative chemotherapy, significantly improves long-term outcomes for patients with locally advanced gastric cancer. However, the choice of the optimal surgical technique remains a matter of debate.Modern trends in gastric cancer surgery emphasize the use of minimally invasive techniques. Studies suggest that minimally invasive surgery reduces surgical trauma, leading to less blood loss, fewer wound complications, faster postoperative recovery, and an earlier start of chemotherapy.Laparoscopic surgery has already become the standard approach for early-stage gastric cancer. However, the role of robot-assisted techniques in gastric cancer treatment has yet to be fully defined.This study aims to explore the advantages and limitations of robotic surgery in gastric cancer treatment as part of a multidisciplinary therapeutic strategy, based on a systematic review of global literature.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>рак желудка</kwd><kwd>робот-ассистированная хирургия</kwd><kwd>гастрэктомия</kwd><kwd>резекция желудка</kwd><kwd>химиотерапия</kwd></kwd-group><kwd-group xml:lang="en"><kwd>gastric cancer</kwd><kwd>robot-assisted surgery</kwd><kwd>gastrectomy</kwd><kwd>gastric resection</kwd><kwd>chemotherapy</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Biondi A, et al. Does a minimum number of 16 retrieved nodes affect survival in curatively resected gastric cancer? European Journal of Surgical Oncology (EJSO). 2015; 41(6): 779-786. doi: 10.1016/j.ejso.2015.03.227.</mixed-citation><mixed-citation xml:lang="en">Biondi A, et al. Does a minimum number of 16 retrieved nodes affect survival in curatively resected gastric cancer? European Journal of Surgical Oncology (EJSO). 2015; 41(6): 779-786. doi: 10.1016/j.ejso.2015.03.227.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Kitano S, et al. Laparoscopy-assisted billroth-I gastrectomy (LADG) for cancer: Our 10 years’ experience. Surgical Laparoscopy, Endoscopy &amp; Percutaneous Techniques. 2002; 12(3): 204-207. doi: 10.1097/00129689-200206000-00021.</mixed-citation><mixed-citation xml:lang="en">Kitano S, et al. Laparoscopy-assisted billroth-I gastrectomy (LADG) for cancer: Our 10 years’ experience. Surgical Laparoscopy, Endoscopy &amp; Percutaneous Techniques. 2002; 12(3): 204-207. doi: 10.1097/00129689-200206000-00021.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Xia X, et al. Objective evaluation of clinical outcomes of laparoscopy-assisted pylorus-preserving gastrectomy for middle-third early gastric cancer. BMC Cancer. 2019; 19(1). doi: 10.1186/s12885-019-5695-0.</mixed-citation><mixed-citation xml:lang="en">Xia X, et al. Objective evaluation of clinical outcomes of laparoscopy-assisted pylorus-preserving gastrectomy for middle-third early gastric cancer. BMC Cancer. 2019; 19(1). doi: 10.1186/s12885-019-5695-0.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Caruso S, et al. Laparoscopic and robot-assisted gastrectomy for gastric cancer: Current considerations. World Journal of Gastroenterology. 2016; 22(25): 5694. doi: 10.3748/wjg.v22.i25.5694.</mixed-citation><mixed-citation xml:lang="en">Caruso S, et al. Laparoscopic and robot-assisted gastrectomy for gastric cancer: Current considerations. World Journal of Gastroenterology. 2016; 22(25): 5694. doi: 10.3748/wjg.v22.i25.5694.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Jung DH, et al. The learning curve associated with laparoscopic total gastrectomy. Gastric Cancer. 2014; 19(1): 264-272. doi: 10.1007/s10120-014-0447-y.</mixed-citation><mixed-citation xml:lang="en">Jung DH, et al. The learning curve associated with laparoscopic total gastrectomy. Gastric Cancer. 2014; 19(1): 264-272. doi: 10.1007/s10120-014-0447-y.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Özer İ, et al. Changing trends in gastric cancer surgery. Balkan Medical Journal. 2017; 34(1): 10-20. doi: 10.4274/balkanmedj.2015.1461.</mixed-citation><mixed-citation xml:lang="en">Özer İ, et al. Changing trends in gastric cancer surgery. Balkan Medical Journal. 2017; 34(1): 10-20. doi: 10.4274/balkanmedj.2015.1461.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Hashizume M, Sugimachi K. Robot-assisted gastric surgery. Surgical Clinics of North America. 2003; 83(6): 1429-1444. doi: 10.1016/s0039-6109(03)00158-0.</mixed-citation><mixed-citation xml:lang="en">Hashizume M, Sugimachi K. Robot-assisted gastric surgery. Surgical Clinics of North America. 2003; 83(6): 1429-1444. doi: 10.1016/s0039-6109(03)00158-0.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">van Boxel GI, Ruurda JP, van Hillegersberg R. Robotic-assisted gastrectomy for Gastric cancer: A European perspective. Gastric Cancer. 2019; 22(5): 909-919. doi: 10.1007/s10120-019-00979-z.</mixed-citation><mixed-citation xml:lang="en">van Boxel GI, Ruurda JP, van Hillegersberg R. Robotic-assisted gastrectomy for Gastric cancer: A European perspective. Gastric Cancer. 2019; 22(5): 909-919. doi: 10.1007/s10120-019-00979-z.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Baral S, et al. Robotic versus laparoscopic gastrectomy for Gastric cancer: A mega meta-analysis. Frontiers in Surgery., 2022; 9. doi: 10.3389/fsurg.2022.895976.</mixed-citation><mixed-citation xml:lang="en">Baral S, et al. Robotic versus laparoscopic gastrectomy for Gastric cancer: A mega meta-analysis. Frontiers in Surgery., 2022; 9. doi: 10.3389/fsurg.2022.895976.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Strong VE, et al. Robotic gastrectomy for gastric adenocarcinoma in the USA: Insights and oncologic outcomes in 220 patients. Annals of Surgical Oncology.2020; 28(2): 742-750. doi: 10.1245/s10434-020-08834-7.</mixed-citation><mixed-citation xml:lang="en">Strong VE, et al. Robotic gastrectomy for gastric adenocarcinoma in the USA: Insights and oncologic outcomes in 220 patients. Annals of Surgical Oncology.2020; 28(2): 742-750. doi: 10.1245/s10434-020-08834-7.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Ma J, et al. Robotic versus laparoscopic gastrectomy for Gastric cancer: A systematic review and meta-analysis. World Journal of Surgical Oncology. 2020; 18(1). doi: 10.1186/s12957-020-02080-7.</mixed-citation><mixed-citation xml:lang="en">Ma J, et al. Robotic versus laparoscopic gastrectomy for Gastric cancer: A systematic review and meta-analysis. World Journal of Surgical Oncology. 2020; 18(1). doi: 10.1186/s12957-020-02080-7.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Terashima M. The 140 years’ journey of Gastric cancer surgery: From the two hands of Billroth to the multiple hands of the robot. Annals of Gastroenterological Surgery. 2021; 5(3): 270-277. doi: 10.1002/ags3.12442.</mixed-citation><mixed-citation xml:lang="en">Terashima M. The 140 years’ journey of Gastric cancer surgery: From the two hands of Billroth to the multiple hands of the robot. Annals of Gastroenterological Surgery. 2021; 5(3): 270-277. doi: 10.1002/ags3.12442.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Yamashita K, et al. History and emerging trends in chemotherapy for Gastric cancer. Annals of Gastroenterological Surgery. 2021; 5(4): 446-456. doi: 10.1002/ags3.12439.</mixed-citation><mixed-citation xml:lang="en">Yamashita K, et al. History and emerging trends in chemotherapy for Gastric cancer. Annals of Gastroenterological Surgery. 2021; 5(4): 446-456. doi: 10.1002/ags3.12439.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Marano L, et al. Robotic versus laparoscopic gastrectomy for Gastric cancer: An umbrella review of systematic reviews and meta-analyses. Updates in Surgery, 2021; 73(5): 1673-1689. doi: 10.1007/s13304-021-01059-7.</mixed-citation><mixed-citation xml:lang="en">Marano L, et al. Robotic versus laparoscopic gastrectomy for Gastric cancer: An umbrella review of systematic reviews and meta-analyses. Updates in Surgery, 2021; 73(5): 1673-1689. doi: 10.1007/s13304-021-01059-7.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Rockall TA, Darzi A. Robot-assisted laparoscopic colorectal surgery. Surgical Clinics of North America. 2003; 83(6): 1463-1468. doi: 10.1016/s0039-6109(03)00156-7.</mixed-citation><mixed-citation xml:lang="en">Rockall TA, Darzi A. Robot-assisted laparoscopic colorectal surgery. Surgical Clinics of North America. 2003; 83(6): 1463-1468. doi: 10.1016/s0039-6109(03)00156-7.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Gutt CN, et al. Robot-assisted abdominal surgery. British Journal of Surgery. 2004; 91(11): 1390-1397. doi: 10.1002/bjs.4700.</mixed-citation><mixed-citation xml:lang="en">Gutt CN, et al. Robot-assisted abdominal surgery. British Journal of Surgery. 2004; 91(11): 1390-1397. doi: 10.1002/bjs.4700.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Федоров А.В., Кригер А.Г., Берелавичус С.В., Ефанов М.Г., Горин Д.С. Робот-ассистированные операции в абдоминальной хирургии // Хирургия. Журнал им. Н.И.Пирогова. – 2010. – №1. – С.16-21.</mixed-citation><mixed-citation xml:lang="en">Fedorov AV, Kriger AG, Berelavichus SV, Efanov MG, Gorin DS. Robotic-assisted abdominal surgery. Pirogov Russian Journal of Surgery. 2010; 1: 16-21. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Park JY, et al. Surgical stress after robot-assisted distal gastrectomy and its economic implications. British Journal of Surgery. 2012; 99(11): 1554-1561. doi: 10.1002/bjs.8887.</mixed-citation><mixed-citation xml:lang="en">Park JY, et al. Surgical stress after robot-assisted distal gastrectomy and its economic implications. British Journal of Surgery. 2012; 99(11): 1554-1561. doi: 10.1002/bjs.8887.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Ojima T, et al. Short-term outcomes of robotic gastrectomy vs laparoscopic gastrectomy for patients with Gastric Cancer. JAMA Surgery. 2021; 156(10): 954. doi: 10.1001/jamasurg.2021.3182.</mixed-citation><mixed-citation xml:lang="en">Ojima T, et al. Short-term outcomes of robotic gastrectomy vs laparoscopic gastrectomy for patients with Gastric Cancer. JAMA Surgery. 2021; 156(10): 954. doi: 10.1001/jamasurg.2021.3182.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Lu J, et al. Robotic versus laparoscopic distal gastrectomy for resectable gastric cancer: A randomized phase 2 trial. Nature Communications. 2024; 15(1). doi: 10.1038/s41467-024-49013-6.</mixed-citation><mixed-citation xml:lang="en">Lu J, et al. Robotic versus laparoscopic distal gastrectomy for resectable gastric cancer: A randomized phase 2 trial. Nature Communications. 2024; 15(1). doi: 10.1038/s41467-024-49013-6.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Liao G, et al. Comparative analysis of robotic gastrectomy and laparoscopic gastrectomy for gastric cancer in terms of their long-term oncological outcomes: A meta-analysis of 3410 gastric cancer patients. World Journal of Surgical Oncology. 2019; 17(1). doi: 10.1186/s12957-019-1628-2.</mixed-citation><mixed-citation xml:lang="en">Liao G, et al. Comparative analysis of robotic gastrectomy and laparoscopic gastrectomy for gastric cancer in terms of their long-term oncological outcomes: A meta-analysis of 3410 gastric cancer patients. World Journal of Surgical Oncology. 2019; 17(1). doi: 10.1186/s12957-019-1628-2.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Loureiro P, et al. Laparoscopic versus robotic gastric cancer surgery: Short-term outcomes–systematic review and meta-analysis of 25,521 patients. Journal of Laparoendoscopic &amp; Advanced Surgical Techniques. 2023; 33(8): 782-800. doi: 10.1089/lap.2023.0136.</mixed-citation><mixed-citation xml:lang="en">Loureiro P, et al. Laparoscopic versus robotic gastric cancer surgery: Short-term outcomes–systematic review and meta-analysis of 25,521 patients. Journal of Laparoendoscopic &amp; Advanced Surgical Techniques. 2023; 33(8): 782-800. doi: 10.1089/lap.2023.0136.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Ma J, et al. Robotic versus laparoscopic gastrectomy for Gastric cancer: A systematic review and meta-analysis [Preprint]. 2020. doi: 10.21203/rs.3.rs-84003/v1.</mixed-citation><mixed-citation xml:lang="en">Ma J, et al. Robotic versus laparoscopic gastrectomy for Gastric cancer: A systematic review and meta-analysis [Preprint]. 2020. doi: 10.21203/rs.3.rs-84003/v1.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Woo Y. Robotic gastrectomy as an oncologically sound alternative to laparoscopic resections for the treatment of early-stage gastric cancers. Archives of Surgery. 2011; 146(9): 1086. doi: 10.1001/archsurg.2011.114.</mixed-citation><mixed-citation xml:lang="en">Woo Y. Robotic gastrectomy as an oncologically sound alternative to laparoscopic resections for the treatment of early-stage gastric cancers. Archives of Surgery. 2011; 146(9): 1086. doi: 10.1001/archsurg.2011.114.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Song J, Hyung WJ. Reply to: 464-625: Re role of robotic gastrectomy using da vinci system compared with laparoscopic gastrectomy: Initial experience of 20 consecutive cases. Surgical Endoscopy. 2009; 24(1): 242-243. doi: 10.1007/s00464-009-0630-0.</mixed-citation><mixed-citation xml:lang="en">Song J, Hyung WJ. Reply to: 464-625: Re role of robotic gastrectomy using da vinci system compared with laparoscopic gastrectomy: Initial experience of 20 consecutive cases. Surgical Endoscopy. 2009; 24(1): 242-243. doi: 10.1007/s00464-009-0630-0.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Gu H, Li W, Zhou L. Application of hand-sewn esophagojejunostomy in laparoscopic total gastrectomy. World Journal of Surgical Oncology. 2024; 22(1). doi: 10.1186/s12957-024-03350-4.</mixed-citation><mixed-citation xml:lang="en">Gu H, Li W, Zhou L. Application of hand-sewn esophagojejunostomy in laparoscopic total gastrectomy. World Journal of Surgical Oncology. 2024; 22(1). doi: 10.1186/s12957-024-03350-4.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Wei JP, et al. Comparing intracorporeal mechanical anastomosis vs. hand-sewn esophagojejunostomy after total laparoscopic gastrectomy for Esophagogastric Junction Cancer: A single-center study. World Journal of Surgical Oncology. 2023; 21(1). doi: 10.1186/s12957-023-02889-y.</mixed-citation><mixed-citation xml:lang="en">Wei JP, et al. Comparing intracorporeal mechanical anastomosis vs. hand-sewn esophagojejunostomy after total laparoscopic gastrectomy for Esophagogastric Junction Cancer: A single-center study. World Journal of Surgical Oncology. 2023; 21(1). doi: 10.1186/s12957-023-02889-y.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Majewska K, et al. Comparison of postoperative outcomes of hand-sewn versus stapled Esophago-jejunal anastomosis during total gastrectomy for gastric cancer in 72 patients: A retrospective, single-center study in Poland. Medical Science Monitor. 2023; 29. doi: 10.12659/msm.938759.</mixed-citation><mixed-citation xml:lang="en">Majewska K, et al. Comparison of postoperative outcomes of hand-sewn versus stapled Esophago-jejunal anastomosis during total gastrectomy for gastric cancer in 72 patients: A retrospective, single-center study in Poland. Medical Science Monitor. 2023; 29. doi: 10.12659/msm.938759.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Castro PM, et al. Hand-sewn versus stapler esophagogastric anastomosis after esophageal ressection: Sistematic Review and meta-analysis. ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo). 2014; 27(3): 216-221. doi: 10.1590/s0102-67202014000300014.</mixed-citation><mixed-citation xml:lang="en">Castro PM, et al. Hand-sewn versus stapler esophagogastric anastomosis after esophageal ressection: Sistematic Review and meta-analysis. ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo). 2014; 27(3): 216-221. doi: 10.1590/s0102-67202014000300014.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Kawamura H, et al. Anastomotic complications after laparoscopic total gastrectomy with esophagojejunostomy constructed by Circular Stapler (orvilTM) versus Linear Stapler (overlap method). Surgical Endoscopy. 2017; 31(12): 5175-5182. doi: 10.1007/s00464-017-5584-z.</mixed-citation><mixed-citation xml:lang="en">Kawamura H, et al. Anastomotic complications after laparoscopic total gastrectomy with esophagojejunostomy constructed by Circular Stapler (orvilTM) versus Linear Stapler (overlap method). Surgical Endoscopy. 2017; 31(12): 5175-5182. doi: 10.1007/s00464-017-5584-z.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Yoshikawa K, et al. Usefulness of the Transoral anvil delivery system for esophagojejunostomy after laparoscopic total gastrectomy: A single-institution comparative study of Transoral Anvil Delivery System and the overlap method. Surgical Laparoscopy, Endoscopy &amp; Percutaneous Techniques. 2018; 28(2). doi: 10.1097/sle.0000000000000495.</mixed-citation><mixed-citation xml:lang="en">Yoshikawa K, et al. Usefulness of the Transoral anvil delivery system for esophagojejunostomy after laparoscopic total gastrectomy: A single-institution comparative study of Transoral Anvil Delivery System and the overlap method. Surgical Laparoscopy, Endoscopy &amp; Percutaneous Techniques. 2018; 28(2). doi: 10.1097/sle.0000000000000495.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Sun D, et al. Comparison between linear stapler and circular stapler after laparoscopic-assisted distal gastrectomy in patients with gastric cancer. Frontiers in Surgery. 2022; 9. doi: 10.3389/fsurg.2022.858236.</mixed-citation><mixed-citation xml:lang="en">Sun D, et al. Comparison between linear stapler and circular stapler after laparoscopic-assisted distal gastrectomy in patients with gastric cancer. Frontiers in Surgery. 2022; 9. doi: 10.3389/fsurg.2022.858236.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Murakami K, et al. Linear or circular stapler? A propensity score-matched, multicenter analysis of intracorporeal esophagojejunostomy following totally laparoscopic total gastrectomy. Surgical Endoscopy. 2019; 34(12): 5265-5273. doi: 10.1007/s00464-019-07313-9.</mixed-citation><mixed-citation xml:lang="en">Murakami K, et al. Linear or circular stapler? A propensity score-matched, multicenter analysis of intracorporeal esophagojejunostomy following totally laparoscopic total gastrectomy. Surgical Endoscopy. 2019; 34(12): 5265-5273. doi: 10.1007/s00464-019-07313-9.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Huang C, et al. A comparison of cervical delta-shaped anastomosis and circular stapled anastomosis after esophagectomy. World Journal of Surgical Oncology. 2017; 15(1). doi: 10.1186/s12957-017-1097-4.</mixed-citation><mixed-citation xml:lang="en">Huang C, et al. A comparison of cervical delta-shaped anastomosis and circular stapled anastomosis after esophagectomy. World Journal of Surgical Oncology. 2017; 15(1). doi: 10.1186/s12957-017-1097-4.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Gong CS, Kim BS, Kim HS. Comparison of totally laparoscopic total gastrectomy using an endoscopic linear stapler with laparoscopic-assisted total gastrectomy using a circular stapler in patients with gastric cancer: A single-center experience’, World Journal of Gastroenterology. 2017; 23(48): 8553-8561. doi: 10.3748/wjg.v23.i48.8553.</mixed-citation><mixed-citation xml:lang="en">Gong CS, Kim BS, Kim HS. Comparison of totally laparoscopic total gastrectomy using an endoscopic linear stapler with laparoscopic-assisted total gastrectomy using a circular stapler in patients with gastric cancer: A single-center experience’, World Journal of Gastroenterology. 2017; 23(48): 8553-8561. doi: 10.3748/wjg.v23.i48.8553.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Son T. Laparoscopic Gastric Cancer Surgery: Current Evidence and Future Perspectives. World Journal of Gastroenterology. 2016; 22(2): 727. doi: 10.3748/wjg.v22.i2.727.</mixed-citation><mixed-citation xml:lang="en">Son T. Laparoscopic Gastric Cancer Surgery: Current Evidence and Future Perspectives. World Journal of Gastroenterology. 2016; 22(2): 727. doi: 10.3748/wjg.v22.i2.727.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Parisi A, et al. Minimally invasive surgery for gastric cancer: A comparison between robotic, laparoscopic and open surgery. World Journal of Gastroenterology. 2017; 23(13): 2376. doi: 10.3748/wjg.v23.i13.2376.</mixed-citation><mixed-citation xml:lang="en">Parisi A, et al. Minimally invasive surgery for gastric cancer: A comparison between robotic, laparoscopic and open surgery. World Journal of Gastroenterology. 2017; 23(13): 2376. doi: 10.3748/wjg.v23.i13.2376.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Okines A, et al. Gastric cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Annals of Oncology. 2010; 21: v50-v54. doi: 10.1093/annonc/mdq164.</mixed-citation><mixed-citation xml:lang="en">Okines A, et al. Gastric cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Annals of Oncology. 2010; 21: v50-v54. doi: 10.1093/annonc/mdq164.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Ajani JA, et al. Gastric cancer, version 3.2016, NCCN clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network. 2016; 14(10): 1286-1312. doi: 10.6004/jnccn.2016.0137.</mixed-citation><mixed-citation xml:lang="en">Ajani JA, et al. Gastric cancer, version 3.2016, NCCN clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network. 2016; 14(10): 1286-1312. doi: 10.6004/jnccn.2016.0137.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Noh SH, et al. Adjuvant Capecitabine Plus Oxaliplatin for gastric cancer after D2 gastrectomy (Classic): 5-year follow-up of an open-label, Randomised Phase 3 trial. The Lancet Oncology. 2014; 15(12): 1389–1396. doi: 10.1016/s1470-2045(14)70473-5.</mixed-citation><mixed-citation xml:lang="en">Noh SH, et al. Adjuvant Capecitabine Plus Oxaliplatin for gastric cancer after D2 gastrectomy (Classic): 5-year follow-up of an open-label, Randomised Phase 3 trial. The Lancet Oncology. 2014; 15(12): 1389–1396. doi: 10.1016/s1470-2045(14)70473-5.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Cunningham D, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. New England Journal of Medicine. 2006; 355(1): 11-20. doi: 10.1056/nejmoa055531.</mixed-citation><mixed-citation xml:lang="en">Cunningham D, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. New England Journal of Medicine. 2006; 355(1): 11-20. doi: 10.1056/nejmoa055531.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Ychou M, et al. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: An FNCLCC and FFCD multicenter phase III trial. Journal of Clinical Oncology. 2011; 29(13): 1715-1721. doi: 10.1200/jco.2010.33.0597.</mixed-citation><mixed-citation xml:lang="en">Ychou M, et al. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: An FNCLCC and FFCD multicenter phase III trial. Journal of Clinical Oncology. 2011; 29(13): 1715-1721. doi: 10.1200/jco.2010.33.0597.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Yoshikawa T, et al. Induction of a pathological complete response by four courses of Neoadjuvant Chemotherapy for gastric cancer: Early results of the randomized phase II compass trial. Annals of Surgical Oncology. 2013; 21(1): 213-219. doi: 10.1245/s10434-013-3055-x.</mixed-citation><mixed-citation xml:lang="en">Yoshikawa T, et al. Induction of a pathological complete response by four courses of Neoadjuvant Chemotherapy for gastric cancer: Early results of the randomized phase II compass trial. Annals of Surgical Oncology. 2013; 21(1): 213-219. doi: 10.1245/s10434-013-3055-x.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Hashemzadeh S, et al. The effects of neoadjuvant chemotherapy on resectability of locally-advanced gastric adenocarcinoma: A clinical trial. International Journal of Surgery. 2014; 12(10): 1061-1069. doi: 10.1016/j.ijsu.2014.08.349.</mixed-citation><mixed-citation xml:lang="en">Hashemzadeh S, et al. The effects of neoadjuvant chemotherapy on resectability of locally-advanced gastric adenocarcinoma: A clinical trial. International Journal of Surgery. 2014; 12(10): 1061-1069. doi: 10.1016/j.ijsu.2014.08.349.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Kang Y-K, et al. Neoadjuvant docetaxel, Oxaliplatin, and S-1 plus surgery and adjuvant S-1 for resectable advanced gastric cancer: Final survival outcomes of the Randomized Phase 3 Prodigy trial. Journal of Clinical Oncology, 2023; 41(16): 4067-4067. doi: 10.1200/jco.2023.41.16_suppl.4067.</mixed-citation><mixed-citation xml:lang="en">Kang Y-K, et al. Neoadjuvant docetaxel, Oxaliplatin, and S-1 plus surgery and adjuvant S-1 for resectable advanced gastric cancer: Final survival outcomes of the Randomized Phase 3 Prodigy trial. Journal of Clinical Oncology, 2023; 41(16): 4067-4067. doi: 10.1200/jco.2023.41.16_suppl.4067.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Ji J, et al. Perioperative chemotherapy of Oxaliplatin combined with S-1 (SOX) versus postoperative chemotherapy of Sox or Oxaliplatin with Capecitabine (XELOX) in locally advanced gastric adenocarcinoma with D2 gastrectomy: A randomized phase III trial (resolve trial). Annals of Oncology. 2019; 30: v877. doi: 10.1093/annonc/mdz394.033.</mixed-citation><mixed-citation xml:lang="en">Ji J, et al. Perioperative chemotherapy of Oxaliplatin combined with S-1 (SOX) versus postoperative chemotherapy of Sox or Oxaliplatin with Capecitabine (XELOX) in locally advanced gastric adenocarcinoma with D2 gastrectomy: A randomized phase III trial (resolve trial). Annals of Oncology. 2019; 30: v877. doi: 10.1093/annonc/mdz394.033.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Wu L, et al. Postoperative morbidity and mortality after neoadjuvant chemotherapy versus upfront surgery for locally advanced gastric cancer: A propensity score matching analysis. Cancer Management and Research, 2019; 11: 6011-6018. doi: 10.2147/cmar.s203880.</mixed-citation><mixed-citation xml:lang="en">Wu L, et al. Postoperative morbidity and mortality after neoadjuvant chemotherapy versus upfront surgery for locally advanced gastric cancer: A propensity score matching analysis. Cancer Management and Research, 2019; 11: 6011-6018. doi: 10.2147/cmar.s203880.</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Hu S-B, et al. Pathological evaluation of Neoadjuvant Chemotherapy in Advanced gastric cancer. World Journal of Surgical Oncology. 2019; 17(1). doi: 10.1186/s12957-018-1534-z.</mixed-citation><mixed-citation xml:lang="en">Hu S-B, et al. Pathological evaluation of Neoadjuvant Chemotherapy in Advanced gastric cancer. World Journal of Surgical Oncology. 2019; 17(1). doi: 10.1186/s12957-018-1534-z.</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Al-Batran S-E, et al. Perioperative chemotherapy with docetaxel, Oxaliplatin, and Fluorouracil/leucovorin (FLOT) versus epirubicin, cisplatin, and fluorouracil or Capecitabine (ECF/ECX) for resectable gastric or gastroesophageal junction (GEJ) adenocarcinoma (flot4-aio): A multicenter, Randomized Phase 3 trial. Journal of Clinical Oncology. 2017; 35(15): 4004-4004. doi: 10.1200/jco.2017.35.15_suppl.4004.</mixed-citation><mixed-citation xml:lang="en">Al-Batran S-E, et al. Perioperative chemotherapy with docetaxel, Oxaliplatin, and Fluorouracil/leucovorin (FLOT) versus epirubicin, cisplatin, and fluorouracil or Capecitabine (ECF/ECX) for resectable gastric or gastroesophageal junction (GEJ) adenocarcinoma (flot4-aio): A multicenter, Randomized Phase 3 trial. Journal of Clinical Oncology. 2017; 35(15): 4004-4004. doi: 10.1200/jco.2017.35.15_suppl.4004.</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Xu W, et al. Neoadjuvant chemotherapy versus direct surgery for locally advanced gastric cancer with Serosal Invasion (ct4nxm0): A propensity score-matched analysis. Frontiers in Oncology. 2021; 11. doi: 10.3389/fonc.2021.718556.</mixed-citation><mixed-citation xml:lang="en">Xu W, et al. Neoadjuvant chemotherapy versus direct surgery for locally advanced gastric cancer with Serosal Invasion (ct4nxm0): A propensity score-matched analysis. Frontiers in Oncology. 2021; 11. doi: 10.3389/fonc.2021.718556.</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Li Ziyu, et al. Correlation of pathological complete response with survival after neoadjuvant chemotherapy in gastric or gastroesophageal junction cancer treated with radical surgery: A meta-analysis. PLOS ONE. 2018; 13(1). doi: 10.1371/journal.pone.0189294.</mixed-citation><mixed-citation xml:lang="en">Li Ziyu, et al. Correlation of pathological complete response with survival after neoadjuvant chemotherapy in gastric or gastroesophageal junction cancer treated with radical surgery: A meta-analysis. PLOS ONE. 2018; 13(1). doi: 10.1371/journal.pone.0189294.</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru"></mixed-citation><mixed-citation xml:lang="en"></mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
